Should the new pneumococcal vaccine be used in high-risk children?
about
Pneumococcal vaccines for sickle cell diseaseHow many episodes of hospital care might be prevented by widespread uptake of pneumococcal conjugate vaccine?Clinical features, aetiology and outcome of empyema in children in the north east of England.Burden of paediatric invasive pneumococcal disease in Europe, 2005.
P2860
Should the new pneumococcal vaccine be used in high-risk children?
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Should the new pneumococcal vaccine be used in high-risk children?
@ast
Should the new pneumococcal vaccine be used in high-risk children?
@en
Should the new pneumococcal vaccine be used in high-risk children?
@nl
type
label
Should the new pneumococcal vaccine be used in high-risk children?
@ast
Should the new pneumococcal vaccine be used in high-risk children?
@en
Should the new pneumococcal vaccine be used in high-risk children?
@nl
prefLabel
Should the new pneumococcal vaccine be used in high-risk children?
@ast
Should the new pneumococcal vaccine be used in high-risk children?
@en
Should the new pneumococcal vaccine be used in high-risk children?
@nl
P2093
P2860
P356
P1476
Should the new pneumococcal vaccine be used in high-risk children?
@en
P2093
P2860
P356
10.1136/ADC.87.1.18
P407
P577
2002-07-01T00:00:00Z